Clinical Locations
Huntsman Cancer Institute - Cancer Hospital South
Veterans Administration Medical Center
Huntsman Cancer Institute - Cancer Hospital North
Specialties
Board Certification
|
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Medical Oncology)
|
Patient Rating
The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.
The scale on which responses are measured is 1 to 5 with 5 being the best score.
Patient Comments
Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.
Dr. Colonna and team were very thorough. I found her advice to be thoughtful and helpful.
she is kind and empathetic towards her patients. Helping guide the patient and all the while letting the patient process and choose their own path of treatment.
Sarah is so sweet! She explained things in a way I can understand. She is very knowledgeable.
She basically said how long do you choose to live. Based on that here are your options.
Dr. Colonna was amazing, she never told me what I should do, but educated me on my options. She gave me HOPE. She is very well educated in BRCA and provides you with wonderful resources and options.
Open, honest, provided alternatives for treatment that would help make my daily life better. Took the time with me to help me understand my options. So grateful!
Fantastic at answering my questions, didn't feel rushed at all, told me about options and were very positive and upbeat
Dr colonna is an amazing doctor. She is so smart, collaborative and patient. I highly, highly recommend her.
Sarah is fantastic! Really explained options and went into detail about risks/benefits
Very friendly. Interested in me. I didn't feel rushed. Made sure I felt taken care of.
I felt so comfortable and really appreciate the amount of time the doctor spent with me.
There aren't many answers for preventing cancer. My doctor did the best she could but I don't feel like it was necessary to go to this appointment.
She was wonderful. I felt she truly understood what I needed and talked through the options and asked me how I would like to proceed. She's very kind, I appreciate her time with me.
I am so thankful for Dr. Colonna. I wish I had found her 15 years ago. Not only does she listen, she demonstrates that she cares. She treats me with dignity and respect and is receptive to my educating myself about my health. I feel supported, which is a really big deal to me personally, but especially being a high-risk patient. I wish every one I knew who is managing hereditary high risk cancer factors could be seen by her. There is no measure to her value in what she does and how she does it.
I was very happy with the doctor and her recommendations
Dr Colonna was extremely thorough and comprehensive and answered every question I had in depth. She is so caring and personal while being extremely knowledgeable. She explained the research and my options very in depth.
Doctor Colonna was excellent and I have already recommended her to two other people to be seen.
Sarah Colonna is a really lovely person. She's very good at what she does and has excellent bedside manner. She was very kind and thorough and made me feel very well cared for.
She is fantastic!
so caring and kind thank you
Dr Colonna treated me with kindness and respect. She listened to my concerns and gave me options on my care. She is definitely a professional.
Phenomenal physician - really knows her stuff and is extremely kind and caring as well.
Dr Colonna is able to collaborate on medical issues that have unclear ends or trajectories
Dr. Colonna is the most intelligent and empathetic doctor I've met at the U of Utah. She leads with clinical excellence and cares deeply about you and your questions. A tremendous professional.
Dr. Colonna seemed oblivious to being a full hour late. She didn't introduce herself. At first I couldn't tell if she was the physician. She was unaware of my surgical history, had not reviewed recent imaging, and was not aware of the type of breast cancer in my family (all in my chart). It did not instill confidence that I had to bring these up, each seemed a surprise to her. Point blank, with no guidance, she began asking me, "Do you need X? Do you need Y?" It would have been beneficial to receive evidence based recommendations from her, rather than be asked to make decisions with a dearth of input or advice. I had to inquire about future follow-up. Again, it seemed like planning/explaining this should've been initiated by her. I read my chart after the visit and discovered that it contains inaccuracies, including my breastfeeding status. Overall interactions felt "off" compared to other physicians I've seen at The U of U. This was an expensive appointment. I was disappointed.
She was very personable and listened to me and had wonderful input for me.
Compassionate health care provider who listens!
I found Sarah V. Colonna MD. warn and caring, comprehensive feedback and a lot of positive energy extremely likeable.
They only wanted to talk about 1 drug. Any other options, questions, drug side effects, I had to ask.
Dr. Colonna will put you at ease with her compassion and extensive knowledge. She is kind, very thoughtful and very thorough. I'm grateful she's my oncologist.
Dr. Colonna is an incredible physician. She took a substantial amount of time to talk with me about my specific medical history & risks and answered every question that we had. She was calm but direct. I entirely trust her to handle my care moving forward. Her clinic demonstrates the highest level of teamwork, and makes me feel confident about the future direction of medicine.
Very good concern for me and good recommendations. However, I wish I had been told prior to my appointment to bring information they were requesting while I was there so I could have felt like I had a more complete assessment at the appointment.
The interaction was very informative
Dr. Sarah Colonna is a genuine and caring doctor. She respected me as an individual with healthcare knowledge. She still provided advice that she would any woman. I am grateful to have found her as a provider for women.
I met her for the first time at this appointment and felt like she listened carefully to me and helped me understand my condition clearly. She was friendly, engaging and helpful.
I really liked Dr. Colonna. She made eye contact, listened attentively, asked questions, and included me in decision-making.
Dr. Colonna is legitimately the best doctor I've ever been to. She was super easy to talk to, a great listener, and instantly made me feel comfortable. I trust her expertise and judgement.
all were excellent!
She is very friendly and caring. She explained things clearly
Superb - great listener; highly sophisticated; excellent care plan
Board Certification and Academic Information
| Academic Departments |
Internal Medicine
-Associate Professor (Clinical) |
|---|---|
| Academic Divisions |
Oncology
|
| Board Certification |
American Board of Internal Medicine
American Board of Internal Medicine (Sub: Medical Oncology)
|
Education history
| Undergraduate | Biology, minor in Religion - Lee University | B.S. |
|---|---|---|
| Professional Medical | Medicine - East Tennessee State University, Quillen College of Medicine | M.D. |
| Residency | Internal Medicine - Wake Forest University | Resident |
| Fellowship | Hematology/Oncology - Vanderbilt University | Fellow |
| Fellowship | Hematology/Oncology - University of Utah, Huntsman Cancer Institute | Fellow |
| Graduate Training | Clinical Investigation - University of Utah | M.S. |
Selected Publications
Journal Article
- Knight JA, Kehm RD, Schwartz L, Frost CJ, Chung WK, Colonna S, Keegan THM, Goldberg M, Houghton LC, Hanna D, Glendon G, Daly MB, Buys SS, Andrulis IL, John EM, Bradbury AR, Terry M (2020). Pre-Pubertal Internalizing Symptoms and Timing of Puberty Onset in Girls. American journal of epidemiology,
- Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna (2017). Breast cancer screening of pregnant and breastfeeding women with BRCA mutations. PMID: 28138892. Breast cancer research and treatment, 162(2), 225-230.
- Colonna SV, Douglas Case L, Lawrence J (2012). A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor. Breast cancer research and treatment, 131(1), 325-31.
- Moser JC, Wei G, Colonna SV, Grossmann KF, Patel S, Hyngstrom J (2020). Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma. Acta oncologica (Stockholm, Sweden), 59(4), 434-437.
- Colonna S, Halwani A, Ying J, Buys S, Sweeney (2015). Women with breast cancer in the Veterans Health Administration: demographics, breast cancer characteristics, and trends. Medical care, 53(4 Suppl 1), S149-55.
- Greenberg S, Slager S, Neil BO, Cooney K, Maughan B, Stopa N, Venne V, Zickmund S, Colonna (2020). What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing. The Prostate, 80(5), 441-450.
- Watt GP, Sung J, Morris EA, Buys SS, Bradbury AR, Brooks JD, Conant EF, Weinstein SP, Kontos D, Woods M, Colonna SV, Liang X, Stein MA, Pike MC, Bernstein J (2020). Association of breast cancer with MRI background parenchymal enhancement: the IMAGINE case-control study. Breast cancer research, 22(1), 138.
- Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brenner H, Brüning T, Buys SS, Caan B, Campa D, Canzian F, Castelao JE, Chang-Claude J, Chanock SJ, Cheng TD, Clarke CL, NBCS Collaborators., Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Dörk T, Dossus L, Dunning AM, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Eriksson M, Evans DG, Fasching PA, Flyger H, Fritschi L, Gago-Dominguez M, García-Sáenz JA, Giles GG, Grip M, Guénel P, Gündert M, Hahnen E, Haiman CA, Håkansson N, Hall P, Hamann U, Hart SN, Hartikainen JM, Hartmann A, He W, Hooning MJ, Hoppe R, Hopper JL, Howell A, Hunter DJ, ABCTB Investigators., kConFab Investigators., Jager A, Jakubowska A, Janni W, John EM, Jung AY, Kaaks R, Keupers M, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kurian AW, Lacey JV, Lambrechts D, Le Marchand L, Lindblom A, Linet M, Luben RN, Lubi'ski J, Lush M, Mannermaa A, Manoochehri M, Margolin S, Martens JWM, Martinez ME, Mavroudis D, Michailidou K, Milne RL, Mulligan AM, Muranen TA, Nevanlinna H, Newman WG, Nielsen SF, Nordestgaard BG, Olshan AF, Olsson H, Orr N, Park-Simon TW, Patel AV, Peissel B, Peterlongo P, Plaseska-Karanfilska D, Prajzendanc K, Prentice R, Presneau N, Rack B, Rennert G, Rennert HS, Rhenius V, Romero A, Roylance R, Ruebner M, Saloustros E, Sawyer EJ, Schmutzler RK, Schneeweiss A, Scott C, Shah M, Smichkoska S, Southey MC, Stone J, Surowy H, Swerdlow AJ, Tamimi RM, Tapper WJ, Teras LR, Terry MB, Tollenaar RAEM, Tomlinson I, Troester MA, Truong T, Vachon CM, Wang Q, Hurson AN, Winqvist R, Wolk A, Ziogas A, Brauch H, García-Closas M, Pharoah PDP, Easton DF, Chenevix-Trench G, Schmidt M (2021). Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast cancer research, 23(1), 86.
- Kaphingst KA, Kohlmann W, Chambers RL, Goodman MS, Bradshaw R, Chan PA, Chavez-Yenter D, Colonna SV, Espinel WF, Everett JN, Gammon A, Goldberg ER, Gonzalez J, Hagerty KJ, Hess R, Kehoe K, Kessler C, Kimball KE, Loomis S, Martinez TR, Monahan R, Schiffman JD, Temares D, Tobik K, Wetter DW, Mann DM, Kawamoto K, Del Fiol G, Buys SS, Ginsburg O, BRIDGE research team (2021). Comparing models of delivery for cancer genetics services among patients receiving primary care who meet criteria for genetic evaluation in two healthcare systems: BRIDGE randomized controlled trial. BMC health services research, 21(1), 542.
- Sutherland N, Espinel W, Grotzke M, Colonna (2020). Unanswered Questions: Hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults. Journal of genetic counseling, 29(4), 625-633.
- Colonna S, Sweetenham J, Burgon TB, Buys SS, Lynch R, Au T, Johnson E, Kubal T, Paculdo D, Acelajado MC, Peabody J (2019). A Better Pathway? Building Consensus and Engaging Providers with Feedback to Improve and Standardize Cancer Care. Clinical breast cancer, 19(2), e376-e384.
- Colonna SV, Higgins AK, Alvarez J, Saville BR, Lawrence J, Abramson V (2016). Analysis of Risk of Recurrence by Subtype in ≤ 1-cm Breast Tumors. PMiD: 26683741. Clinical breast cancer, 16(3), 223-31.
- Baron K, Moser JC, Patel S, Grossmann KF, Colonna SV, Hyngstrom J (2021). Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 antibodies. Journal of oncology pharmacy practice, 27(3), 555-559.
- Moser JC, Chen D, Hu-Lieskovan S, Grossmann KF, Patel S, Colonna SV, Ying J, Hyngstrom J (2019). Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab. Cancer medicine, 8(18), 7637-7643.
- Silvestri V, Leslie G, Barnes DR, CIMBA Group., Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, Barrowdale D, Benitez J, Bonanni B, Borg A, Buys SS, Caldés T, Caligo MA, Capalbo C, Campbell I, Chung WK, Claes KBM, Colonna SV, Cortesi L, Couch FJ, de la Hoya M, Diez O, Ding YC, Domchek S, Easton DF, Ejlertsen B, Engel C, Evans DG, Feliubadalò L, Foretova L, Fostira F, Géczi L, Gerdes AM, Glendon G, Godwin AK, Goldgar DE, Hahnen E, Hogervorst FBL, Hopper JL, Hulick PJ, Isaacs C, Izquierdo A, James PA, Janavicius R, Jensen UB, John EM, Joseph V, Konstantopoulou I, Kurian AW, Kwong A, Landucci E, Lesueur F, Loud JT, Machackova E, Mai PL, Majidzadeh-A K, Manoukian S, Montagna M, Moserle L, Mulligan AM, Nathanson KL, Nevanlinna H, Ngeow J, Nikitina-Zake L, Offit K, Olah E, Olopade OI, Osorio A, Papi L, Park SK, Pedersen IS, Perez-Segura P, Petersen AH, Pinto P, Porfirio B, Pujana MA, Radice P, Rantala J, Rashid MU, Rosenzweig B, Rossing M, Santamariña M, Schmutzler RK, Senter L, Simard J, Singer CF, Solano AR, Southey MC, Steele L, Steinsnyder Z, Stoppa-Lyonnet D, Tan YY, Teixeira MR, Teo SH, Terry MB, Thomassen M, Toland AE, Torres-Esquius S, Tung N, van Asperen CJ, Vega A, Viel A, Vierstraete J, Wappenschmidt B, Weitzel JN, Wieme G, Yoon SY, Zorn KK, McGuffog L, Parsons MT, Hamann U, Greene MH, Kirk JA, Neuhausen SL, Rebbeck TR, Tischkowitz M, Chenevix-Trench G, Antoniou AC, Friedman E, Ottini (2020). Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). JAMA oncology, 6(8), 1218-1230.
- Choi YH, Terry MB, Daly MB, MacInnis RJ, Hopper JL, Colonna S, Buys SS, Andrulis IL, John EM, Kurian AW, Briollais (2021). Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants. JAMA oncology, 7(4), 585-592.
- Colonna S, Curtin K, Johnson E, Kohlmann W, Wright J, Kirchhoff A, Tavtigian S, Schiffman (2019). Family History of Breast Cancer Associated with Breast Cancer in Survivors of Hodgkin Lymphoma. International journal of cancer and clinical research, 6(1),
- Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, Nielsen HR, Lee A, Yang X, McGuffog L, Parsons MT, Andrulis IL, Arnold N, Belotti M, Borg Å, Buecher B, Buys SS, Caputo SM, Chung WK, Colas C, Colonna SV, Cook J, Daly MB, de la Hoya M, de Pauw A, Delhomelle H, Eason J, Engel C, Evans DG, Faust U, Fehm TN, Fostira F, Fountzilas G, Frone M, Garcia-Barberan V, Garre P, Gauthier-Villars M, Gehrig A, Glendon G, Goldgar DE, Golmard L, Greene MH, Hahnen E, Hamann U, Hanson H, Hassan T, Hentschel J, Horvath J, Izatt L, Janavicius R, Jiao Y, John EM, Karlan BY, Kim SW, Konstantopoulou I, Kwong A, Laugé A, Lee JW, Lesueur F, Mebirouk N, Meindl A, Mouret-Fourme E, Musgrave H, Ngeow Yuen Yie J, Niederacher D, Park SK, Pedersen IS, Ramser J, Ramus SJ, Rantala J, Rashid MU, Reichl F, Ritter J, Rump A, Santamariña M, Saule C, Schmidt G, Schmutzler RK, Senter L, Shariff S, Singer CF, Southey MC, Stoppa-Lyonnet D, Sutter C, Tan Y, Teo SH, Terry MB, Thomassen M, Tischkowitz M, Toland AE, Torres D, Vega A, Wagner SA, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Spurdle AB, Easton DF, Chenevix-Trench G, Ottini L, Antoniou A (2022). Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. Journal of clinical oncology, JCO2102112.
- Morra A, Schreurs MAC, Andrulis IL, Anton-Culver H, Augustinsson A, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brauch H, Broeks A, Buys SS, Camp NJ, Castelao JE, Cessna MH, Chang-Claude J, Chung WK, NBCS Collaborators, Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Dennis J, Devilee P, Dörk T, Dunning AM, Dwek M, Easton DF, Eccles DM, Eriksson M, Evans DG, Fasching PA, Fehm TN, Figueroa JD, Flyger H, Gabrielson M, Gago-Dominguez M, García-Closas M, García-Sáenz JA, Genkinger J, Grassmann F, Gündert M, Hahnen E, Haiman CA, Hamann U, Harrington PA, Hartikainen JM, Hoppe R, Hopper JL, Houlston RS, Howell A, ABCTB Investigators, kConFab Investigators, Jakubowska A, Janni W, Jernström H, John EM, Johnson N, Jones ME, Kristensen VN, Kurian AW, Lambrechts D, Le Marchand L, Lindblom A, Lubi'ski J, Lux MP, Mannermaa A, Mavroudis D, Mulligan AM, Muranen TA, Nevanlinna H, Nevelsteen I, Neven P, Newman WG, Obi N, Offit K, Olshan AF, Park-Simon TW, Patel AV, Peterlongo P, Phillips KA, Plaseska-Karanfilska D, Polley EC, Presneau N, Pylkäs K, Rack B, Radice P, Rashid MU, Rhenius V, Robson M, Romero A, Saloustros E, Sawyer EJ, Schmutzler RK, Schuetze S, Scott C, Shah M, Smichkoska S, Southey MC, Tapper WJ, Teras LR, Tollenaar RAEM, Tomczyk K, Tomlinson I, Troester MA, Vachon CM, van Veen EM, Wang Q, Wendt C, Wildiers H, Winqvist R, Ziogas A, Hall P, Pharoah PDP, Adank MA, Hollestelle A, Schmidt MK, Hooning M (2023). Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer medicine, 12(15), 16142-16162.
- Kast K, John EM, Hopper JL, Andrieu N, Noguès C, Mouret-Fourme E, Lasset C, Fricker JP, Berthet P, Mari V, Salle L, Schmidt MK, Ausems MGEM, Garcia EBG, van de Beek I, Wevers MR, Evans DG, Tischkowitz M, Lalloo F, Cook J, Izatt L, Tripathi V, Snape K, Musgrave H, Sharif S, Murray J, EMBRACE Collaborators, Colonna SV, Andrulis IL, Daly MB, Southey MC, de la Hoya M, Osorio A, Foretova L, Berkova D, Gerdes AM, Olah E, Jakubowska A, Singer CF, Tan Y, Augustinsson A, Rantala J, Simard J, Schmutzler RK, Milne RL, Phillips KA, Terry MB, Goldgar D, van Leeuwen FE, Mooij TM, Antoniou AC, Easton DF, Rookus MA, Engel (2023). Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium. Breast cancer research, 25(1), 72.
- Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Abu-Ful Z, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baert T, Freeman LEB, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Bogdanova NV, Bojesen SE, Bonanni B, Brenner H, Brucker SY, Buys SS, Castelao JE, Chan TL, Chang-Claude J, Chanock SJ, Choi JY, Chung WK, NBCS Collaborators, Colonna SV, CTS Consortium, Cornelissen S, Couch FJ, Czene K, Daly MB, Devilee P, Dörk T, Dossus L, Dwek M, Eccles DM, Ekici AB, Eliassen AH, Engel C, Evans DG, Fasching PA, Fletcher O, Flyger H, Gago-Dominguez M, Gao YT, García-Closas M, García-Sáenz JA, Genkinger J, Gentry-Maharaj A, Grassmann F, Guénel P, Gündert M, Haeberle L, Hahnen E, Haiman CA, Håkansson N, Hall P, Harkness EF, Harrington PA, Hartikainen JM, Hartman M, Hein A, Ho WK, Hooning MJ, Hoppe R, Hopper JL, Houlston RS, Howell A, Hunter DJ, Huo D, ABCTB Investigators, Ito H, Iwasaki M, Jakubowska A, Janni W, John EM, Jones ME, Jung A, Kaaks R, Kang D, Khusnutdinova EK, Kim SW, Kitahara CM, Koutros S, Kraft P, Kristensen VN, Kubelka-Sabit K, Kurian AW, Kwong A, Lacey JV, Lambrechts D, Le Marchand L, Li J, Linet M, Lo WY, Long J, Lophatananon A, Mannermaa A, Manoochehri M, Margolin S, Matsuo K, Mavroudis D, Menon U, Muir K, Murphy RA, Nevanlinna H, Newman WG, Niederacher D, O'Brien KM, Obi N, Offit K, Olopade OI, Olshan AF, Olsson H, Park SK, Patel AV, Patel A, Perou CM, Peto J, Pharoah PDP, Plaseska-Karanfilska D, Presneau N, Rack B, Radice P, Ramachandran D, Rashid MU, Rennert G, Romero A, Ruddy KJ, Ruebner M, Saloustros E, Sandler DP, Sawyer EJ, Schmidt MK, Schmutzler RK, Schneider MO, Scott C, Shah M, Sharma P, Shen CY, Shu XO, Simard J, Surowy H, Tamimi RM, Tapper WJ, Taylor JA, Teo SH, Teras LR, Toland AE, Tollenaar RAEM, Torres D, Torres-Mejía G, Troester MA, Truong T, Vachon CM, Vijai J, Weinberg CR, Wendt C, Winqvist R, Wolk A, Wu AH, Yamaji T, Yang XR, Yu JC, Zheng W, Ziogas A, Ziv E, Dunning AM, Easton DF, Hemingway H, Hamann U, Kuchenbaecker K (2023). Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome medicine, 15(1), 7.
- Hazra A, Goldstein KM, Waltz SE, Chiba A, Colonna SV, Kelley MJ, Moss HA, Zullig L (2024). Summary and Roadmap of Breast Cancer Research in the Veterans Affairs. Military medicine,
- Kaphingst KA, Kohlmann WK, Lorenz Chambers R, Bather JR, Goodman MS, Bradshaw RL, Chavez-Yenter D, Colonna SV, Espinel WF, Everett JN, Flynn M, Gammon A, Harris A, Hess R, Kaiser-Jackson L, Lee S, Monahan R, Schiffman JD, Volkmar M, Wetter DW, Zhong L, Mann DM, Ginsburg O, Sigireddi M, Kawamoto K, Del Fiol G, Buys S (2024). Uptake of Cancer Genetic Services for Chatbot vs Standard-of-Care Delivery Models: The BRIDGE Randomized Clinical Trial. JAMA network open, 7(9), e2432143.
- McDonald JA, Liao Y, Knight JA, John EM, Kurian AW, Daly M, Buys SS, Huang Y, Frost CJ, Andrulis IL, Colonna SV, Friedlander ML, Hopper JL, Chung WK, Genkinger JM, MacInnis RJ, Terry MB, Kathleen Cuningham Foundation Consortium investigator (2024). Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk. JAMA network open, 7(8), e2427441.
- Kehm RD, Genkinger JM, Knight JA, MacInnis RJ, Liao Y, Li S, Weideman PC, Chung WK, Kurian AW, Colonna SV, Andrulis IL, Buys SS, Daly MB, John EM, Hopper JL, Terry M (2025). Physical Activity during Adolescence and Early Adulthood and Breast Cancer Risk before Age 40 Years. Cancer epidemiology, biomarkers & prevention, 34(1), 108-116.
- MacInnis RJ, Jenkins MA, Milne RL, John EM, Daly MB, Andrulis IL, Colonna SV, Phillips KA, kConFab Investigators, Le Marchand L, Newcomb PA, Phipps AI, Schmit SL, Macrae FA, Buchanan DD, Gallinger S, Pai RK, Samadder NJ, Giles GG, Southey MC, Hopper JL, Terry M (2025). Menopausal hormone therapy: assessing associations with breast and colorectal cancers by familial risk. JNCI cancer spectrum, 9(1),
- Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla MK, Abubakar M, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baten A, Behrens S, Bermisheva M, de Gonzalez AB, Bia'kowska K, Boddicker N, Bodelon C, Bogdanova NV, Bojesen SE, Brantley KD, Brauch H, Brenner H, Camp NJ, Canzian F, Castelao JE, Cessna MH, Chang-Claude J, Chenevix-Trench G, Chung WK, NBCS Collaborators, Colonna SV, Couch FJ, Cox A, Cross SS, Czene K, Daly MB, Devilee P, Dörk T, Dunning AM, Eccles DM, Eliassen AH, Engel C, Eriksson M, Evans DG, Fasching PA, Fletcher O, Flyger H, Fritschi L, Gago-Dominguez M, Gentry-Maharaj A, González-Neira A, Guénel P, Hahnen E, Haiman CA, Hamann U, Hartikainen JM, Ho V, Hodge J, Hollestelle A, Honisch E, Hooning MJ, Hoppe R, Hopper JL, Howell S, Howell A, ABCTB Investigators, kConFab Investigators, Jakovchevska S, Jakubowska A, Jernström H, Johnson N, Kaaks R, Khusnutdinova EK, Kitahara CM, Koutros S, Kristensen VN, Lacey JV, Lambrechts D, Lejbkowicz F, Lindblom A, Lush M, Mannermaa A, Mavroudis D, Menon U, Murphy RA, Nevanlinna H, Obi N, Offit K, Park-Simon TW, Patel AV, Peng C, Peterlongo P, Pita G, Plaseska-Karanfilska D, Pylkäs K, Radice P, Rashid MU, Rennert G, Roberts E, Rodriguez J, Romero A, Rosenberg EH, Saloustros E, Sandler DP, Sawyer EJ, Schmutzler RK, Scott CG, Shu XO, Southey MC, Stone J, Taylor JA, Teras LR, van de Beek I, Willett W, Winqvist R, Zheng W, Vachon CM, Schmidt MK, Hall P, MacInnis RJ, Milne RL, Pharoah PDP, Simard J, Antoniou AC, Easton DF, Michailidou (2024). Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction. Breast cancer research, 26(1), 189.
- Ho PJ, Loo CKY, Goh MH, Abubakar M, Ahearn TU, Andrulis IL, Antonenkova NN, Aronson KJ, Augustinsson A, Behrens S, Bodelon C, Bogdanova NV, Bolla MK, Brantley K, Brenner H, Byers H, Camp NJ, Castelao JE, Cessna MH, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Choi JY, Colonna SV, Czene K, Daly MB, Derouane F, Dörk T, Eliassen AH, Engel C, Eriksson M, Evans DG, Fletcher O, Fritschi L, Gago-Dominguez M, Genkinger JM, Geurts-Giele WRR, Glendon G, Hall P, Hamann U, Ho CYS, Ho WK, Hooning MJ, Hoppe R, Howell A, Humphreys K, ABCTB Investigators, kConFab Investigators, SGBCC Investigators, MyBrCa Investigators, Ito H, Iwasaki M, Jakubowska A, Jernström H, John EM, Johnson N, Kang D, Kim SW, Kitahara CM, Ko YD, Kraft P, Kwong A, Lambrechts D, Larsson S, Li S, Lindblom A, Linet M, Lissowska J, Lophatananon A, MacInnis RJ, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Michailidou K, Milne RL, Taib NAM, Muir K, Murphy RA, Newman WG, O'Brien KM, Obi N, Olopade OI, Panayiotidis MI, Park SK, Park-Simon TW, Patel AV, Peterlongo P, Plaseska-Karanfilska D, Pylkäs K, Rashid MU, Rennert G, Rodriguez J, Saloustros E, Sandler DP, Sawyer EJ, Scott CG, Shahi S, Shu XO, Shulman K, Simard J, Southey MC, Stone J, Taylor JA, Teo SH, Teras LR, Terry MB, Torres D, Vachon CM, Van Houdt M, Verhoeven J, Weinberg CR, Wolk A, Yamaji T, Yip CH, Zheng W, Hartman M, Li (2025). Overlap of high-risk individuals across family history, genetic & non-genetic breast cancer risk models: Analysis of 180,398 women from European & Asian ancestries.
- Zhong L, Bather JR, Goodman MS, Kaiser-Jackson L, Volkmar M, Bradshaw RL, Lorenz Chambers R, Chavez-Yenter D, Colonna SV, Maxwell W, Flynn M, Gammon A, Hess R, Mann DM, Monahan R, Yi Y, Sigireddi M, Wetter DW, Kawamoto K, Del Fiol G, Buys SS, Kaphingst K (2025). Importance of Prior Patient Interactions With the Healthcare System to Engaging With Pretest Cancer Genetic Services via Digital Health Tools Among Unaffected Primary Care Patients: Findings From the BRIDGE Trial. Health services research, e14652.
- Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, Barkardottir RB, Berger LPV, Berrington de Gonzalez A, Berthet P, Bia'kowska K, Bjørge L, Blanco AM, Blok MJ, Bobolis KA, Bogdanova NV, Brenton JD, Butz H, Buys SS, Caligo MA, Campbell I, Castillo C, Claes KBM, Colonna SV, Cook LS, Daly MB, Dansonka-Mieszkowska A, de la Hoya M, deFazio A, DePersia A, Ding YC, Doherty JA, Domchek SM, Dörk T, Einbeigi Z, Engel C, Evans DG, Foretova L, Fortner RT, Fostira F, Foti MC, Friedman E, Frone MN, Ganz PA, Gentry-Maharaj A, Glendon G, Godwin AK, González-Neira A, Greene MH, Gronwald J, Guerrieri-Gonzaga A, Hamann U, Hansen TVO, Harris HR, Hauke J, Heitz F, Hogervorst FBL, Hooning MJ, Hopper JL, Huff CD, Huntsman DG, Imyanitov EN, Izatt L, Jakubowska A, James PA, Janavicius R, John EM, Kar S, Karlan BY, Kennedy CJ, Kiemeney LALM, Konstantopoulou I, Kupryjanczyk J, Laitman Y, Lavie O, Lawrenson K, Lester J, Lesueur F, Lopez-Pleguezuelos C, Mai PL, Manoukian S, May T, McNeish IA, Menon U, Milne RL, Modugno F, Mongiovi JM, Montagna M, Moysich KB, Neuhausen SL, Nielsen FC, Noguès C, Oláh E, Olopade OI, Osorio A, Papi L, Pathak H, Pearce CL, Pedersen IS, Peixoto A, Pejovic T, Peng PC, Peshkin BN, Peterlongo P, Powell CB, Prokofyeva D, Pujana MA, Radice P, Rashid MU, Rennert G, Richenberg G, Sandler DP, Sasamoto N, Setiawan VW, Sharma P, Sieh W, Singer CF, Snape K, Sokolenko AP, Soucy P, Southey MC, Stoppa-Lyonnet D, Sutphen R, Sutter C, Tan YY, Teixeira MR, Terry KL, Thomsen LCV, Tischkowitz M, Toland AE, Van Gorp T, Vega A, Velez Edwards DR, Webb PM, Weitzel JN, Wentzensen N, Whittemore AS, Winham SJ, Wu AH, Yadav S, Yu Y, Ziogas A, Berchuck A, Couch FJ, Goode EL, Goodman MT, Monteiro AN, Offit K, Ramus SJ, Risch HA, Schildkraut JM, Thomassen M, Simard J, Easton DF, Jones MR, Chenevix-Trench G, Gayther SA, Antoniou AC, Pharoah PD (2025). Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer. NPJ genomic medicine, 10(1), 73.
- Ho PJ, Loo CKY, Lim RJY, Goh MH, Abubakar M, Ahearn TU, Andrulis IL, Antonenkova NN, Aronson KJ, Augustinsson A, Behrens S, Bodelon C, Bogdanova NV, Bolla MK, Brantley KD, Brenner H, Byers H, Camp NJ, Castelao JE, Cessna MH, Chang-Claude J, Chanock SJ, Chenevix-Trench G, Choi JY, Colonna SV, Czene K, Daly MB, Derouane F, Dörk T, Eliassen AH, Engel C, Eriksson M, Evans DG, Fletcher O, Fritschi L, Gago-Dominguez M, Genkinger JM, Geurts-Giele WRR, Glendon G, Hall P, Hamann U, Ho CYS, Ho WK, Hooning MJ, Hoppe R, Howell A, Humphreys K, Ito H, Iwasaki M, Jakubowska A, Jernström H, John EM, Johnson N, Kang D, Kim SW, Kitahara CM, Ko YD, Kraft P, Kwong A, Lambrechts D, Larsson S, Li S, Lindblom A, Linet M, Lissowska J, Lophatananon A, MacInnis RJ, Mannermaa A, Manoukian S, Margolin S, Matsuo K, Michailidou K, Milne RL, Mohd Taib NA, Muir KR, Murphy RA, Newman WG, O'Brien KM, Obi N, Olopade OI, Panayiotidis MI, Park SK, Park-Simon TW, Patel AV, Peterlongo P, Plaseska-Karanfilska D, Pylkäs K, Rashid MU, Rennert G, Rodriguez J, Saloustros E, Sandler DP, Sawyer EJ, Scott CG, Shahi S, Shu XO, Shulman K, Simard J, Southey MC, Stone J, Taylor JA, Teo SH, Teras LR, Terry MB, Torres D, Vachon CM, Houdt MV, Verhoeven J, Weinberg CR, Wolk A, Yamaji T, Yip CH, Zheng W, Hartman M, Li J, On Behalf Of The Abctb Investigators, kConFab Investigators, MyBrCa Investigators, Sgbcc Investigator (2025). Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women. Cancers, 17(21),
- Yang R, MacInnis RJ, Milne RL, Nguyen-Dumont T, Maxwell WF, Genkinger JM, Glendon G, Kathleen Cuningham Foundation Consortium for Research Into Familial Breast Cancer (kConFab), Ross EA, Andrulis IL, Colonna SV, Daly M, John EM, Kurian AW, Terry MB, Hopper JL, Southey MC, Phillips KA, Li (2026). Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study. BMC medicine,
Book Chapter
- Colonna SV, Werner (2015). Breast cancer bone metastases.
- Colonna SV, Goff L, Berlin (2013). Biliary Tree Cancer.
- Colonna SV, Gammon (2016). Management of the Patient with a Genetic Predisposition for Breast Cancer.
Editorial
- Kohlmann W, Champine M, Colonna S (2015). Communicating Genetic Test Results to Patients and Their Families.
Abstract
- Colonna SV, Curtin K, Kohlmann W, Wright J, Tavtigian S, Schiffman (2015). Family history of breast cancer in Hodgkin disease and future risk of breast cancer. Journal of clinical oncology, 33(suppl), abstr 1522.
- Colonna SV, Higgins AK, Alvarez J, Saville B, Lawrence JA, Abramson V (2013). Analysis of recurrence risk by subtype in <1cm breast tumors. Journal of clinical oncology,
- Halwani A, Colonna SV, Ying J, Buys S, Sweeney C (2014). Geographic distribution of rural-urban status of women with breast cancer in the Veterans Health Administration using two schemes: Rural Urban Continuum and Rural Urban Commuting Areas.
- Colonna SV, Douglas Case L, Lawrence J (2009). Correlation of the Metabolic Syndrome with Estrogen Receptor Negative Breast Cancer in a Retrospective Review.
- Udomaksorn S, Stenehjem D, Welch BM, Cheng Y, Anderson L, Colonna S, Neumayer L, Brixner (2013). Evaluation of variable relevance and accessibility to support personalized medicine in breast cancer.
- Colonna SV, Halwani A, Ying J, Sweeney C, Buys S (2014). Breast cancer treatment among rural and urban veterans at the Veterans Health Administration: also presented as a poster.